Q4 2023 Holdings
Filed 2024-02-14 | 19 holdings | $165.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $33.6M | 730,000 | 20.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $26.6M | 70,000 | 16.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $19.2M | 230,000 | 11.6% |
| Spdr Biotech ETF TR(XBI)Put | UNIT | 78464A870 | $16.1M | 180,000 | 9.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $12.4M | 340,000 | 7.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $12.4M | 155,346 | 7.5% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $10.1M | 880,000 | 6.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $6.9M | 233,659 | 4.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.1M | 266,856 | 3.7% |
| Ironwood Pharmaceuticals Inc(IRWD)Call | COM CL A | 46333X108 | $5.7M | 500,000 | 3.5% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $4.6M | 325,000 | 2.8% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $3.3M | 359,446 | 2.0% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $2.1M | 1,503,554 | 1.3% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $1.7M | 1,292,316 | 1.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $1.7M | 293,945 | 1.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.2M | 444,804 | 0.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $577.6K | 10,000 | 0.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $476.3K | 453,614 | 0.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $361.0K | 33,000 | 0.2% |